Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 11 March 2027
- Last conf. stmt
- 25 February 2026
Autifony Therapeutics Limited
- Incorporated
- 25 February 2011 (15 years)
- Previously known as
- Newincco 1091 Limited (until 1 June 2011)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Rana Al-Hallaq
- Accounts type
- Group
- Region
- East of England
- Address
- Stevenage Bioscience CatalystGunnels Wood RoadStevenageSG1 2FX
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 6 active
Officer details are public data from the Companies House register.
Selin, Hannah Louise
Secretary · Appointed 7 May 2025
Al-Hallaq, Rana
Director · Appointed 15 April 2019
American
Born June 1975 (51)
Corporate Director · Appointed 12 March 2018
Director · Appointed 19 August 2011
British
Born October 1965 (61)
Director · Appointed 23 May 2011
British
Born April 1948 (78)
Large, Charles Henry
Director · Appointed 23 May 2011
British
Born May 1967 (59)
Officer history (10 former)
7 May 2025
Appointed Selin, Hannah Louise as Secretary
31 January 2024
Resigned Pande, Atul Chandra, Dr as Director
15 April 2019
15 April 2019
Appointed Al-Hallaq, Rana as Director
12 March 2018
12 March 2018
15 December 2017
Resigned Bhaman, Maina as Director
15 December 2017
27 January 2015
Resigned Baxter, Allan as Director
1 April 2014
Appointed Pande, Atul Chandra, Dr as Director
14 February 2013
19 August 2011
Appointed Baxter, Allan as Director
19 August 2011
19 August 2011
Resigned Alvaro, Giuseppe as Director
19 August 2011
Appointed Bhaman, Maina as Director
23 May 2011
23 May 2011
Appointed Alvaro, Giuseppe as Director
23 May 2011
23 May 2011
23 May 2011
Appointed Large, Charles Henry as Director
23 May 2011
23 May 2011
25 February 2011
25 February 2011
25 February 2011
25 February 2011
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 6 April 2016
Owns 25–50% of shares
Holds 25–50% of voting rights
Llp
Reg. no. Oc333709
Holdings 1
Companies where Autifony Therapeutics Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Former controllers (2)
12 January 2023
Ceased Pfizer Inc — Owns 25–50% of shares
1 November 2021
Ceased SVLS Life Sciences Fund V LP — Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 24 June 2026 | Group of companies' accounts | 30 September 2025 | ||
| 24 March 2026 | Confirmation statement with no updates | 25 February 2026 | ||
| 20 March 2026 | Replacement filing for the appointment of a director | |||
| 3 March 2026 | Replacement filing for the appointment of a director | |||
| 17 October 2025 | Insolvency filing |
Some other companies at this address
Other companies in this industry
Oxford
Sandwich
Newcastle Upon Tyne
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →